Intra-articular and Intravenous Infliximab in the Treatment of Resistant Seronegative Oligoarthritis of the Knee.
Phase of Trial: Phase II
Latest Information Update: 19 May 2016
At a glance
- Drugs Infliximab; Infliximab; Methylprednisolone
- Indications Arthritis
- Focus Therapeutic Use
- Acronyms SOKS
- 10 May 2016 Status changed from recruiting to discontinued as were unable to recruit participants.
- 13 Oct 2010 New trial record